Anne Jenisch, APN | |
2160 South First Avenue, Building 110, Room 6201, Maywood, IL 60523 | |
(708) 327-2236 | |
Not Available |
Full Name | Anne Jenisch |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Acute Care |
Location | 2160 South First Avenue, Maywood, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699293936 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SA2100X | Clinical Nurse Specialist - Acute Care | 209.016453 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Anne Jenisch, APN 2160 S 1st Ave, Maywood, IL 60153-3328 Ph: (630) 532-0476 | Anne Jenisch, APN 2160 South First Avenue, Building 110, Room 6201, Maywood, IL 60523 Ph: (708) 327-2236 |
News Archive
There is an increased risk of fetal heart problems when mothers carry particular antibodies associated with rheumatic diseases, according to an abstract presented by Yale School of Medicine researchers at the Society for Maternal-Fetal Medicine Conference in San Francisco.
Researchers in the United States have conducted an analysis suggesting that students returning to university campuses this fall (2020) may have increased the number of new cases of coronavirus disease 2019 (COVID-19) within surrounding areas.
African-Americans and Africans who swapped their typical diets for just two weeks similarly exchanged their respective risks of colon cancer as reflected by alterations of their gut bacteria, according to an international study led by researchers at the University of Pittsburgh School of Medicine published online today in Nature Communications.
Pfizer and Kohlberg Kravis Roberts & Co L.P. (together with its affiliates, "KKR") today announced they have entered into an agreement whereby an affiliate of KKR will acquire Pfizer's Capsugel business for $2.375 billion in cash. Capsugel, the world leader in hard capsules and an innovator in drug-delivery systems, generated approximately $750 million in revenue and manufactured more than 180 billion hard capsules in 2010.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).
› Verified 5 days ago
Ms. Nancy L Porter, APN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-4921 | |
Mary M Brush, APN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-327-3019 | |
Erin Fruth, APN, AGCNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Loyola Medical Center, Department Of Urology, Maywood, IL 60153 Phone: 708-216-5100 Fax: 708-216-1699 | |
Jaclynn Wente, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-327-2482 | |
Sima Patel, Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-6048 | |
Joyce Despe, APN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-1918 |